Krka Introduces Cardiovascular Range To New Eastern European Markets

Reporting double-digit growth in the first half of 2019, Krka says it has mined marketing opportunities in new eastern European markets by introducing its established treatments for cardiovascular diseases

Opportunities
Krka is rolling out a range of combination cardiovascular drugs in Eastern Europe and the Commonwealth of Independent States • Source: Shutterstock

More from Products

More from Generics Bulletin